US 11730775
Methods for treatment of Clostridium difficile infection or recurrence or symptoms thereof
granted A61KA61K35/37A61K35/74
Quick answer
US patent 11730775 (Methods for treatment of Clostridium difficile infection or recurrence or symptoms thereof) held by Seres Therapeutics, Inc. expires Mon Aug 17 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Seres Therapeutics, Inc.
- Grant date
- Tue Aug 22 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 17 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 32
- CPC classes
- A61K, A61K35/37, A61K35/74, A61K35/741, A61K35/742